These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 12869589

  • 1. Two tandemly linked interferon-gamma-activated sequence elements in the promoter of glycosylation-dependent cell adhesion molecule 1 gene synergistically respond to prolactin in mouse mammary epithelial cells.
    Hou Z, Srivastava S, Mistry MJ, Herbst MP, Bailey JP, Horseman ND.
    Mol Endocrinol; 2003 Oct; 17(10):1910-20. PubMed ID: 12869589
    [Abstract] [Full Text] [Related]

  • 2. Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter.
    Brockman JL, Schuler LA.
    Mol Cell Endocrinol; 2005 Jul 15; 239(1-2):45-53. PubMed ID: 15885880
    [Abstract] [Full Text] [Related]

  • 3. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
    Gao J, Hughes JP, Auperin B, Buteau H, Edery M, Zhuang H, Wojchowski DM, Horseman ND.
    Mol Endocrinol; 1996 Jul 15; 10(7):847-56. PubMed ID: 8813725
    [Abstract] [Full Text] [Related]

  • 4. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S, Volarevic S, Moriggl R, Mercep M, Groner B.
    Mol Endocrinol; 1998 Apr 15; 12(4):556-67. PubMed ID: 9544991
    [Abstract] [Full Text] [Related]

  • 5. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
    Carsol JL, Gingras S, Simard J.
    Mol Endocrinol; 2002 Jul 15; 16(7):1696-710. PubMed ID: 12089361
    [Abstract] [Full Text] [Related]

  • 6. Glycosylation-dependent cell adhesion molecule 1 (GlyCAM 1) is induced by prolactin and suppressed by progesterone in mammary epithelium.
    Hou Z, Bailey JP, Vomachka AJ, Matsuda M, Lockefeer JA, Horseman ND.
    Endocrinology; 2000 Nov 15; 141(11):4278-83. PubMed ID: 11089563
    [Abstract] [Full Text] [Related]

  • 7. Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells.
    Srivastava S, Matsuda M, Hou Z, Bailey JP, Kitazawa R, Herbst MP, Horseman ND.
    J Biol Chem; 2003 Nov 14; 278(46):46171-8. PubMed ID: 12952963
    [Abstract] [Full Text] [Related]

  • 8. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
    Aoki N, Matsuda T.
    J Biol Chem; 2000 Dec 15; 275(50):39718-26. PubMed ID: 10993888
    [Abstract] [Full Text] [Related]

  • 9. Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells.
    Qian L, Lopez V, Seo YA, Kelleher SL.
    Am J Physiol Cell Physiol; 2009 Aug 15; 297(2):C369-77. PubMed ID: 19494234
    [Abstract] [Full Text] [Related]

  • 10. PRL activates the cyclin D1 promoter via the Jak2/Stat pathway.
    Brockman JL, Schroeder MD, Schuler LA.
    Mol Endocrinol; 2002 Apr 15; 16(4):774-84. PubMed ID: 11923474
    [Abstract] [Full Text] [Related]

  • 11. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
    Nevalainen MT, Xie J, Bubendorf L, Wagner KU, Rui H.
    Mol Endocrinol; 2002 May 15; 16(5):1108-24. PubMed ID: 11981045
    [Abstract] [Full Text] [Related]

  • 12. Prolactin-dependent activation of a tyrosine phosphorylated DNA binding factor in mouse mammary epithelial cells.
    Welte T, Garimorth K, Philipp S, Doppler W.
    Mol Endocrinol; 1994 Aug 15; 8(8):1091-102. PubMed ID: 7527899
    [Abstract] [Full Text] [Related]

  • 13. Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells.
    Ooi GT, Hurst KR, Poy MN, Rechler MM, Boisclair YR.
    Mol Endocrinol; 1998 May 15; 12(5):675-87. PubMed ID: 9605930
    [Abstract] [Full Text] [Related]

  • 14. Mammary gland factor activated by prolactin on mammary epithelial cells and acute-phase response factor activated by interleukin-6 in liver cells share DNA binding and transactivation potential.
    Standke GJ, Meier VS, Groner B.
    Mol Endocrinol; 1994 Apr 15; 8(4):469-77. PubMed ID: 7519723
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
    Friedrichsen BN, Galsgaard ED, Nielsen JH, Møldrup A.
    Mol Endocrinol; 2001 Jan 15; 15(1):136-48. PubMed ID: 11145745
    [Abstract] [Full Text] [Related]

  • 16. Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5.
    Fleenor DE, Freemark M.
    Endocrinology; 2001 Jul 15; 142(7):2805-10. PubMed ID: 11415999
    [Abstract] [Full Text] [Related]

  • 17. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
    Ferrag F, Chiarenza A, Goffin V, Kelly PA.
    Mol Endocrinol; 1996 Apr 15; 10(4):451-60. PubMed ID: 8721989
    [Abstract] [Full Text] [Related]

  • 18. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.
    Pfitzner E, Jähne R, Wissler M, Stoecklin E, Groner B.
    Mol Endocrinol; 1998 Oct 15; 12(10):1582-93. PubMed ID: 9773981
    [Abstract] [Full Text] [Related]

  • 19. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G.
    Mol Endocrinol; 2001 Nov 15; 15(11):1941-52. PubMed ID: 11682625
    [Abstract] [Full Text] [Related]

  • 20. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
    Luo G, Yu-Lee L.
    J Biol Chem; 1997 Oct 24; 272(43):26841-9. PubMed ID: 9341115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.